Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Immunological and psychological dysfunction in patients receiving immunotherapy for chronic fatigue syndrome.

Hickie I, Lloyd A, Wakefield D.

Aust N Z J Psychiatry. 1992 Jun;26(2):249-56.

PMID:
1642616
[PubMed - indexed for MEDLINE]
2.

A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.

Lloyd A, Hickie I, Wakefield D, Boughton C, Dwyer J.

Am J Med. 1990 Nov;89(5):561-8.

PMID:
2146875
[PubMed - indexed for MEDLINE]
3.

Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression.

Lloyd A, Hickie I, Hickie C, Dwyer J, Wakefield D.

Clin Exp Immunol. 1992 Jan;87(1):76-9.

PMID:
1733640
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A psychodynamic view of the chronic fatigue syndrome. The role of object relations in etiology and treatment.

Taerk G, Gnam W.

Gen Hosp Psychiatry. 1994 Sep;16(5):319-25.

PMID:
7995502
[PubMed - indexed for MEDLINE]
5.

Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation.

Peakman M, Deale A, Field R, Mahalingam M, Wessely S.

Clin Immunol Immunopathol. 1997 Jan;82(1):83-91.

PMID:
9000046
[PubMed - indexed for MEDLINE]
6.

Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis.

Natelson BH, LaManca JJ, Denny TN, Vladutiu A, Oleske J, Hill N, Bergen MT, Korn L, Hay J.

Am J Med. 1998 Sep 28;105(3A):43S-49S.

PMID:
9790481
[PubMed - indexed for MEDLINE]
7.

Cell-mediated immune function and the outcome of chronic fatigue syndrome.

Wilson A, Hickie I, Lloyd A, Hadzi-Pavlovic D, Wakefield D.

Int J Immunopharmacol. 1995 Aug;17(8):691-4.

PMID:
8847164
[PubMed - indexed for MEDLINE]
8.

A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome.

Peterson PK, Shepard J, Macres M, Schenck C, Crosson J, Rechtman D, Lurie N.

Am J Med. 1990 Nov;89(5):554-60.

PMID:
2239975
[PubMed - indexed for MEDLINE]
9.

Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome.

Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, Tymms K, Wakefield D, Dwyer J, Lloyd A.

Am J Med. 1997 Jul;103(1):38-43.

PMID:
9236484
[PubMed - indexed for MEDLINE]
10.

Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial.

Lloyd AR, Hickie I, Brockman A, Hickie C, Wilson A, Dwyer J, Wakefield D.

Am J Med. 1993 Feb;94(2):197-203.

PMID:
8430715
[PubMed - indexed for MEDLINE]
11.

Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.

Raison CL, Lin JM, Reeves WC.

Brain Behav Immun. 2009 Mar;23(3):327-37. doi: 10.1016/j.bbi.2008.11.005. Epub 2008 Dec 11.

PMID:
19111923
[PubMed - indexed for MEDLINE]
12.

Immunological aspects of chronic fatigue syndrome.

Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G.

Autoimmun Rev. 2009 Feb;8(4):287-91. doi: 10.1016/j.autrev.2008.08.003. Epub 2008 Sep 16. Review.

PMID:
18801465
[PubMed - indexed for MEDLINE]
13.

Immunological abnormalities in the chronic fatigue syndrome.

Lloyd AR, Wakefield D, Boughton CR, Dwyer JM.

Med J Aust. 1989 Aug 7;151(3):122-4.

PMID:
2787888
[PubMed - indexed for MEDLINE]
14.

Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.

Vercoulen JH, Swanink CM, Zitman FG, Vreden SG, Hoofs MP, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G.

Lancet. 1996 Mar 30;347(9005):858-61.

PMID:
8622391
[PubMed - indexed for MEDLINE]
15.

Psychobehavioral and immunological characteristics of adult people with chronic fatigue and patients with chronic fatigue syndrome.

Masuda A, Nozoe SI, Matsuyama T, Tanaka H.

Psychosom Med. 1994 Nov-Dec;56(6):512-8.

PMID:
7871106
[PubMed - indexed for MEDLINE]
16.

Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents.

ter Wolbeek M, van Doornen LJ, Kavelaars A, van de Putte EM, Schedlowski M, Heijnen CJ.

Brain Behav Immun. 2007 Nov;21(8):1063-74. Epub 2007 Jun 1.

PMID:
17544255
[PubMed - indexed for MEDLINE]
17.

Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.

Mihaylova I, DeRuyter M, Rummens JL, Bosmans E, Maes M.

Neuro Endocrinol Lett. 2007 Aug;28(4):477-83.

PMID:
17693977
[PubMed - indexed for MEDLINE]
18.

Immunological abnormalities in patients with chronic fatigue syndrome.

Tirelli U, Marotta G, Improta S, Pinto A.

Scand J Immunol. 1994 Dec;40(6):601-8.

PMID:
7997849
[PubMed - indexed for MEDLINE]
19.

[Role of pathological delayed-type hypersensitivity in chronic fatigue syndrome: importance of the evaluation of lymphocyte activation by flow cytometry and the measurement of urinary neopterin].

Brunet JL, Fatoohi F, Liaudet AP, Cozon GJ.

Allerg Immunol (Paris). 2002 Feb;34(2):38-44. French.

PMID:
11933752
[PubMed - indexed for MEDLINE]
20.

A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome.

Hickie IB, Wilson AJ, Wright JM, Bennett BK, Wakefield D, Lloyd AR.

J Clin Psychiatry. 2000 Sep;61(9):643-8.

PMID:
11030484
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk